Back to search
FDAFDA · Food and drugs·Recall number D-058-2013

Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 00591-0540-05.

Published November 28, 2012 · Recall initiated: September 21, 2012

Summary

FDA records drug Class I recall D-058-2013, published November 28, 2012 and initiated September 21, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 4,874 bottles; Lot: Lot #: 519406A, 521759A, Exp 04/14. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationwide
Lot
Lot #: 519406A, 521759A, Exp 04/14
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 00591-0540-05. recalled?

Yes. FDA published recall D-058-2013 on November 28, 2012. Reported hazard: Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release